Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Renee R. Ram"'
Autor:
Michael E Abram, Renee R Ram, Nicolas A Margot, Tiffany L Barnes, Kirsten L White, Christian Callebaut, Michael D Miller
Publikováno v:
PLoS ONE, Vol 12, Iss 2, p e0172206 (2017)
T97A is an HIV-1 integrase polymorphism associated with integrase strand transfer inhibitor (INSTI) resistance. Using pooled data from 16 clinical studies, we investigated the prevalence of T97A (pre-existing and emergent) and its impact on INSTI sus
Externí odkaz:
https://doaj.org/article/4d3f83567e2248c28ddccd47298f8e72
Autor:
Qi Liu, Chien-Hung Chou, Eda Canales, Roman Sakowicz, Steven Bondy, Tomas Cihlar, Albert Liclican, Diana M. Brainard, Anita Niedziela-Majka, William Rowe, Nikolai Novikov, Shekeba Ahmadyar, John R. Somoza, Randall L. Halcomb, Cheryl K. McDonald, Carina E. Cannizzaro, Nicolas Margot, Debi Jin, George Stepan, Qiaoyin Wu, Eric Hu, Judy Mwangi, Stephanie A. Leavitt, Todd C. Appleby, Robert L. Anderson, Scott E. Lazerwith, Schroeder Scott D, Tse Winston C, Gediminas Brizgys, Rebecca Begley, Yili Xu, Scott Sellers, Scott A. Wolckenhauer, Wesley I. Sundquist, Derek Hansen, Philip Morganelli, Andrew Mulato, Sheila Clancy, Xiaohong Liu, Anna Chiu, Eric S. Daar, Renee R. Ram, S. Swaminathan, Anne E. Chester, Melanie H. Wong, Ya-Pei Liu, John O. Link, Michael Graupe, Luong K. Tsai, Christian Callebaut, Latesh Lad, William E. Lee, Rujuta A. Bam, Terrence Z. Cai, Bing Lu, John K. Ling, Roland D. Saito, Magdeleine Hung, Armando G. Villaseñor, Peter Ruane, Nikos Pagratis, Martin S. Rhee, David Koditek, Gordon Crofoot, Giuseppe A. Papalia, Stephen R. Yant, Rob Hyland, Helen Yu, Jim Zheng, Jennifer R. Zhang, Gary I. Sinclair, Jiayao Li, Eric Singer
Publikováno v:
Nature
Oral antiretroviral agents provide life-saving treatments for millions of people living with HIV, and can prevent new infections via pre-exposure prophylaxis1–5. However, some people living with HIV who are heavily treatment-experienced have limite
Autor:
Melanie H. Wong, Helen Yu, Daniel Gonik, Derek Hansen, Wesley I. Sundquist, Debi Jin, Anita Niedziela-Majka, Nikolai Novikov, William M. McDougall, Shekeba Ahmadyar, Albert Liclican, Jill M. Perreira, Andrew Mulato, George Stepan, Jennifer R. Zhang, Bing Lu, Magdeleine Hung, Giuseppe A. Papalia, Renee R. Ram, John O. Link, Kevin Chou, Abraham L. Brass, Eric E. Paoli, Stephen R. Yant, Jim Zheng, Eric Singer, Eric Hu, Tomas Cihlar, Schroeder Scott D, Tse Winston C
Publikováno v:
Nat Med
People living with HIV (PLWH) have expressed concern about the life-long burden and stigma associated with taking pills daily and can experience medication fatigue that might lead to suboptimal treatment adherence and the emergence of drug-resistant
Autor:
Renee R, Ram, Paul, Duatschek, Nicolas, Margot, Michael, Abram, Romas, Geleziunas, Joseph, Hesselgesser, Christian, Callebaut
Publikováno v:
Antiviral therapy. 25(3)
Vesatolimod (VES; GS-9620) is a Toll-like receptor 7 (TLR7) agonist that directly activates human plasmacytoid dendritic cells (pDCs) and B lymphocytes resulting in direct and indirect production of cytokines and immune activation. VES is being evalu
Autor:
Margot N; Gilead Sciences, Inc., 333 Lakeside Dr., Foster City, CA 94404, USA., Vanderveen L; Gilead Sciences, Inc., 333 Lakeside Dr., Foster City, CA 94404, USA., Naik V; Gilead Sciences, Inc., 333 Lakeside Dr., Foster City, CA 94404, USA., Ram R; Gilead Sciences, Inc., 333 Lakeside Dr., Foster City, CA 94404, USA., Parvangada PC; Gilead Sciences, Inc., 333 Lakeside Dr., Foster City, CA 94404, USA., Martin R; Gilead Sciences, Inc., 333 Lakeside Dr., Foster City, CA 94404, USA., Rhee M; Gilead Sciences, Inc., 333 Lakeside Dr., Foster City, CA 94404, USA., Callebaut C; Gilead Sciences, Inc., 333 Lakeside Dr., Foster City, CA 94404, USA.
Publikováno v:
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2022 Mar 31; Vol. 77 (4), pp. 989-995.
Autor:
Margot N; Gilead Sciences, Inc., Foster City, California, USA Nicolas.Margot@gilead.com., Ram R; Gilead Sciences, Inc., Foster City, California, USA., Rhee M; Gilead Sciences, Inc., Foster City, California, USA., Callebaut C; Gilead Sciences, Inc., Foster City, California, USA.
Publikováno v:
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2021 Feb 17; Vol. 65 (3). Date of Electronic Publication: 2021 Feb 17 (Print Publication: 2021).
Autor:
Margot N; Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, CA 94404, USA., Ram R; Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, CA 94404, USA., McNicholl I; Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, CA 94404, USA., Haubrich R; Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, CA 94404, USA., Callebaut C; Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, CA 94404, USA.
Publikováno v:
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2020 Aug 01; Vol. 75 (8), pp. 2249-2252.
Autor:
Margot N; Gilead Sciences, Inc., Foster City, California, USA nicolas.margot@gilead.com., Ram R; Gilead Sciences, Inc., Foster City, California, USA., Abram M; Gilead Sciences, Inc., Foster City, California, USA., Haubrich R; Gilead Sciences, Inc., Foster City, California, USA., Callebaut C; Gilead Sciences, Inc., Foster City, California, USA.
Publikováno v:
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2020 Mar 24; Vol. 64 (4). Date of Electronic Publication: 2020 Mar 24 (Print Publication: 2020).
Autor:
Rizzardini G; ASST Fatebenefratelli-Sacco, Milan, Italy.; School of Clinical Medicine, Faculty of Health Science University of the Witwatersrand, Johannesburg, South Africa., Gori A; Infectious Diseases Unit, San Gerardo Hospital, Monza, Italy., Miralles C; Complejo Hospitalario Universitario de Vigo, Vigo., Olalla J; Hospital Universitario Cruces, Bilbao, Spain., Molina JM; Department of Infectious Diseases, Saint Louis Hospital, Assistance Publique Hôpitaux de Paris, University Paris Diderot., Raffi F; Department of Infectious Diseases, University Hospital of Nantes and CIC 1413, INSERM, Nantes, France., Kumar P; Division of Infectious Diseases, Georgetown University, Washington, DC, USA., Antinori A; HIV/AIDS Department, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy., Ramgopal M; Midway Immunology and Research Center, Fort Pierce, Florida, USA., Stellbrink HJ; ICH Study Center, Hamburg, Germany., Das M; Gilead Sciences, Inc., Foster City, California, USA., Chu H; Gilead Sciences, Inc., Foster City, California, USA., Ram R; Gilead Sciences, Inc., Foster City, California, USA., Garner W; Gilead Sciences, Inc., Foster City, California, USA., Shao Y; Gilead Sciences, Inc., Foster City, California, USA., Chuck SK; Gilead Sciences, Inc., Foster City, California, USA., Piontkowsky D; Gilead Sciences, Inc., Foster City, California, USA., Haubrich RH; Gilead Sciences, Inc., Foster City, California, USA.
Publikováno v:
AIDS (London, England) [AIDS] 2019 Aug 01; Vol. 33 (10), pp. 1583-1593.
Autor:
Cox S; Clinical Virology, Gilead Sciences, Inc., Foster City, CA, USA. Electronic address: stephanie.cox@gilead.com., Margot N; Clinical Virology, Gilead Sciences, Inc., Foster City, CA, USA., Ram R; Clinical Virology, Gilead Sciences, Inc., Foster City, CA, USA., Johnson A; Clinical Virology, Gilead Sciences, Inc., Foster City, CA, USA., Miller M; Clinical Virology, Gilead Sciences, Inc., Foster City, CA, USA., Callebaut C; Clinical Virology, Gilead Sciences, Inc., Foster City, CA, USA.
Publikováno v:
Antiviral research [Antiviral Res] 2017 Jul; Vol. 143, pp. 22-29. Date of Electronic Publication: 2017 Mar 28.